Versatile AlivaMab® Platforms Enabling Discovery and Engineering Biologics for Complex Targets and Modalities

In biologics drug discovery and engineering, success for challenging targets and advanced modalities requires experienced integration of versatile platforms and processes. This presentation will showcase our ‘fit-for-purpose’ philosophy, including a suite of AlivaMab® Mouse strains, enabling the discovery of human antibodies, VHH, common light chain BiSAbs, and TCRm for the engineering for next-generation modalities, illustrating the agility and adaptability of our comprehensive approach.